Header Logo

Connection

WARREN C FISKUS to Bevacizumab

Back to Details
This is a "connection" page, showing publications WARREN C FISKUS has written about Bevacizumab.
WARREN C FISKUS
Connection Strength
0.019
Bevacizumab
  1. Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo. Breast Cancer Res Treat. 2012 Apr; 132(3):1063-72.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.